Composition and method for the treatment of type I diabetes
A method of treating type I diabetes comprising administering a therapeutically effective amount of 64 Zn-enriched zinc.
1. A method of treating type I diabetes comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising a 64 Zn e compound or a salt thereof, wherein the 64 Zn e compound or a salt thereof is at least 80% 64 Zn e .
2. The method of claim 1 , further comprising a diluent or an excipient.
3. The method of claim 2 , wherein the diluent is deuterium-depleted water.
4. The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 95% 64 Zn e .
5. The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 99% 64 Zn e .
6. The method of claim 1 , wherein the composition contains between 0.05 mg and 110 mg of 64 Zn e .
7. The method of claim 6 , wherein the composition contains between 1 and 10 mg of 64 Zn e .
8. The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 90% 64 Zn e and the composition is an aqueous solution in which 64 Zn e is present at a concentration of between 0.1 mg/ml and 10 mg/ml.
9. The method of claim 1 , wherein 64 Zn e is in a form of a salt of asparaginate (chemical formula—C 4 H 5 O 4 N 64 Zn e ) with 2 aspartic acid molecules.
10. The method of claim 1 , wherein the composition is administered by injection.
11. The method of claim 1 , wherein the composition is administered orally.